SEC Form 4 · accession 0001140361-15-004238
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Craig
Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 12:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2015 | M | 1,500 | $56.95 | A | 13,984 | D | |
| Common StockF1 | Feb 3, 2015 | S | 1,000 | $157.049 | D | 12,984 | D | |
| Common StockF2 | Feb 3, 2015 | S | 500 | $157.71 | D | 12,484 | D | |
| Common Stock | Feb 4, 2015 | M | 700 | $56.95 | A | 13,184 | D | |
| Common Stock | Feb 4, 2015 | S | 700 | $156.50 | D | 12,484 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF3 | $56.95 | Feb 3, 2015 | M | 1,500 | D | — | Feb 13, 2015 | Common Stock | 1,500 | 1,434 | D |
| Non-Qualified Stock OptionF3 | $56.95 | Feb 4, 2015 | M | 700 | D | — | Feb 13, 2015 | Common Stock | 700 | 734 | D |
Explanation of responses
- F1The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $156.50 to $157.40, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
- F2The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $157.52 to $157.91, inclusive.
- F3Grant of options to buy shares of common stock that vested on 02/14/2009.